Total RNA was isolated from formalin-fixed paraffin-embedded (FFPE) tissue sections using the
RNeasy FFPE Kit (Qiagen, Valencia, CA, USA). RNA isolation from samples stored in RNAlater was carried out using the
QIAGEN Rneasy Kit (Qiagen, Valencia, CA, USA), following the manufacturer’s protocol. To confirm the presence of the fusion transcripts, we performed reverse transcription PCR (RT-PCR) with oligonucleotide primers designed to specifically anneal to either side of the putative RTK fusion transcript breakpoint (
Supplementary Table S3). First strand cDNA was synthesized from 0.5 to 1 µg total RNA using the
MMLV RT kit (Evrogen, Moscow, Russia); cDNA was then amplified using the
qPCRmix-HS SYBR kit (Evrogen, Moscow, Russia), and real-time RT-PCR was carried out using CFX96 Touch™ real-time PCR equipment (BIO-RAD, Hercules, CA, USA) in a 25 μL final volume containing 1× qPCRmix-HS SYBR, 25 pmol of primer pair (
Table 1), and 1 μL of cDNA per reaction. PCR products were then assessed using melting curve analysis and by electrophoresis in 2% agarose gels. For the PCR products obtained, Sanger sequencing was carried out by Evrogen (Moscow, Russia) in both directions using the same primers as for RT-PCR amplification.
Rabushko E., Sorokin M., Suntsova M., Seryakov A.P., Kuzmin D.V., Poddubskaya E, & Buzdin A.A. (2022). Experimentally Deduced Criteria for Detection of Clinically Relevant Fusion 3′ Oncogenes from FFPE Bulk RNA Sequencing Data. Biomedicines, 10(8), 1866.